in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
DSM's net profit falls 13% in the first quarter as performance materials sales decline
5:16 AM MDT | May 2, 2013 | Francinia Protti-Alvarez
DSM's core net profit fell 13.4%, to €129 million ($170 million) during the first quarter of 2013, compared with the same period last year when it stood at €149 million, the company announced today. Ebitda, meanwhile, rose by 1.6% from €306 million during the first quarter of 2012, to €311 million in the latest reporting period. Net sales also increased by about 4%, to €2.38 billion during the first quarter of 2013, from €2.29 billion in the same period the year before. Life sciences delivered the company's growth once again, driven...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee